Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02365285

Racial Differences in Vagal Control of Glucose Homeostasis (RDVCGH)

Sponsor: Doris Duke Charitable Foundation

Conditions Obesity

Interventions Galantamine Heparin Intralipid Placebo Oral Capsule

Updated 10 times since 2017 Last updated: Feb 28, 2019 Started: Mar 31, 2015 Primary completion: Oct 5, 2017 Completion: Oct 5, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Obesity, this trial is completed. The trial is conducted by Doris Duke Charitable Foundation and has accumulated 10 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Apr 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

Status: Recruiting → Completed
Oct 2018 — Apr 2019 [monthly]

Recruiting PHASE1_PHASE2

▶ Show 5 earlier versions

Sep 2018 — Oct 2018 [monthly]

Recruiting PHASE1_PHASE2
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE1_PHASE2
Mar 2017 — Jun 2018 [monthly]

Recruiting PHASE1_PHASE2
Feb 2017 — Mar 2017 [monthly]

Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Doris Duke Charitable Foundation
Vanderbilt University Medical Center

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States